Abacavir

CAS Number136470-78-5
Molecular FormulaC14H18N6O
Molecular Weight286.339
InChI KeyMCGSCOLBFJQGHM-SCZZXKLOSA-N
LogP0.9
Synonyms
  • abacavir
  • 136470-78-5
  • (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
  • ((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
  • Avacavir
  • WR2TIP26VS
  • DTXSID4046444
  • CHEBI:421707
  • 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-
  • NSC-742406
  • [(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl]methanol
  • [(1s,4r)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]-1-cyclopent-2-enyl]methanol
  • {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
  • {(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
  • 2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S-cis)-
  • (-)-CIS-4-(2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL
  • (1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentene-1-methanol
  • 2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S,4R)-
  • abacavirum
  • ((1S,4R)-4-(2-amino-6-(cyclopropylamino)purin-9-yl)-1-cyclopent-2-enyl)methanol
  • ((1S-cis)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
  • (+)-abacavir sulfate
  • RefChem:551202
  • (1R,4S)-abacavir sulfate
  • J05AF06
  • DTXCID601478426
  • 620-487-9
  • Ziagen
  • Abacavir [INN]
  • 1592U89
  • Abacavir (INN)
  • [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol
  • MFCD00903850
  • ABC
  • Abacavir (1.0 mg/mL in Methanol)
  • C14H18N6O
  • (+/-)-Abacavir
  • Abacavir [INN:BAN]
  • UNII-WR2TIP26VS
  • NSC742406
  • Ziagen (TM)(*Succinate salt*)
  • NCGC00164560-01
  • Abacavir; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-; 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S-cis)-; (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol; 1592U89; ABC
  • Abacavir (Standard)
  • ABACAVIR [MI]
  • ABACAVIR [VANDF]
  • AVACAVIR [VANDF]
  • ABACAVIR [MART.]
  • ABACAVIR [WHO-DD]
  • Epitope ID:137341
  • ABACAVIR [EMA EPAR]
  • CHEMBL1380
  • SCHEMBL38632
  • Abacavir - Bio-X trade mark
  • MLS006010117
  • orb1309177
  • SCHEMBL7795337
  • SCHEMBL23391283
  • GTPL11152
  • Abacavir (1 mg/mL in Methanol)
  • MCGSCOLBFJQGHM-SCZZXKLOSA-N
  • GLXC-06957
  • SRCA-00004
  • MSK11262
  • BDBM50366816
  • EBC-12628
  • HY-17423R
  • AKOS024464970
  • AC-1299
  • CCG-267342
  • CS-1354
  • DB01048
  • DT-0030
  • NA10018
  • NSC 742406
  • (+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
  • NCGC00164560-02
  • NCGC00164560-05
  • NCGC00164560-17
  • BA166801
  • HY-17423
  • SMR004701251
  • SY009678
  • A0401
  • A2694
  • NS00007385
  • T1267
  • C07624
  • D07057
  • EN300-258000
  • AB01566826_01
  • F463835
  • Q304330
  • BRD-K17443395-065-01-4
  • (+/-)-cis-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol

Applications:

HPLC MS Method for Analysis of Abacavir on Primesep 100 Column

October 27, 2026

HPLC Method for Abacavir on Primesep 100 by SIELC Technologies

HPLC Method for Analysis of Abacavir on Primesep 100 Column by SIELC Technologies

Abacavir, often written as ABC, is a medication with the formula C14H18N6O. It is used primarily as a part of HIV/AIDS treatments. As a nucleoside reverse transcriptase inhibitor and a guanosine, it works through inhibiting viral replication. It is in the World Health Organization’s List of Essential Medicines. You can find detailed UV spectra of Abacavir and information about its various lambda maxima by visiting the following link.

Abacavir can be retained, and analyzed using a Primesep 100 mixed-mode stationary phase column. The analysis utilizes a gradient method with a simple mobile phase consisting of water, acetonitrile (MeCN), and ammonium formate as a buffer. Detection is carried out using LC MS

ColumnPrimesep 100, 2.1 x 100 mm, 5 µm, 100 A, dual ended
Mobile PhaseGradient MeCN/H2O – 60/40 to 80/20% over 10 mi
BufferAmmonium formate pH 3.0 – 20 mM
Flow Rate0.2 ml/min
DetectionLC MS ESI SIM 287 (M+H)+ , UV 296 nm
Class of CompoundsMedication
Analyzing CompoundsAbacavir

Application Column

Primesep 100

Column Diameter: 2.1 mm
Column Length: 100 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: dual ended

Add to cart
Application Analytes:
Abacavir

Application Detection:
UV Detection
LC MS Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.

HPLC Method for Analysis of Abacavir on Primesep 100 Column

October 26, 2026

HPLC Method for Abacavir on Primesep 100 by SIELC Technologies

HPLC Method for Analysis of Abacavir on Primesep 100 Column by SIELC Technologies

Abacavir, often written as ABC, is a medication with the formula C14H18N6O. It is used primarily as a part of HIV/AIDS treatments. As a nucleoside reverse transcriptase inhibitor and a guanosine, it works through inhibiting viral replication. It is in the World Health Organization’s List of Essential Medicines. You can find detailed UV spectra of Abacavir and information about its various lambda maxima by visiting the following link.

Abacavir can be retained, and analyzed using a Primesep 100 mixed-mode stationary phase column. The analysis utilizes an isocratic method with a simple mobile phase consisting of water, acetonitrile (MeCN), and H2SO4 as a buffer. Detection is carried out using UV

ColumnPrimesep 100, 4.6 x 100 mm, 5 µm, 100 A, dual ended
Mobile PhaseMeCN/H2O – 40/60%
BufferH2SO4  – 0.1%
Flow Rate1 ml/min
DetectionUV 296 nm
LOD*2 ppb
*LOD was determined for this combination of instrument, method, and analyte, and it can vary from one laboratory to another even when the same general type of analysis is being performed.
Class of CompoundsMedication
Analyzing CompoundsAbacavir

Application Column

Primesep 100

Column Diameter: 4.6 mm
Column Length: 100 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: dual ended

Add to cart
Application Analytes:
Abacavir

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.

Uv-Vis Spectrum of Abacavir 

October 26, 2026

Access the UV-Vis Spectrum SIELC Library

If you are looking for optimized HPLC method to analyze Abacavir check our HPLC Applications library

UV/Vis.: λmax: 192 nm, 210 nm, 222 nm, 256 nm, 296 nm

For optimal results in HPLC analysis, it is recommended to measure absorbance at a wavelength that matches the absorption maximum of the compound(s) being analyzed. The UV spectrum shown can assist in selecting an appropriate wavelength for your analysis. Please note that certain mobile phases and buffers may block wavelengths below 230 nm, rendering absorbance measurement at these wavelengths ineffective. If detection below 230 nm is required, it is recommended to use acetonitrile and water as low UV-transparent mobile phases, with phosphoric acid and its salts, sulfuric acid, and TFA as buffers.
For some compounds, the UV-Vis Spectrum is affected by the pH of the mobile phase. This compound was diluted in a mixture of water and acetonitrile. The method was done with a mixture of water and acetonitrile.

 

 

 

 

 

 

 

Application Analytes:
Abacavir
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.